Table 2.
Variables | P | OR | 95% CI |
---|---|---|---|
Age | 0.544 | 1.023 | 0.950–1.102 |
Male | 0.430 | 0.573 | 0.114–2.286 |
Hypertension | 0.094 | 0.307 | 0.077–1.223 |
Diabetes mellitusa | 0.966 | 0.966 | 0.197–4.743 |
Hyperlipidemiab | 0.823 | 0.784 | 0.093–6.578 |
Previous symptomatic ICH | 0.026 | 4.343 | 1.192–15.823 |
Previous antiplatelet usec | 0.316 | 2.057 | 0.503–8.414 |
Previous anticoagulant used | 0.040 | 19.889 | 1.149–344.360 |
NIHSS scoree | 0.513 | 1.020 | 0.961–1.084 |
ICH volume | 0.176 | 1.012 | 0.995–1.030 |
Presence of cSAH | 0.045 | 5.012 | 1.036–24.239 |
Adjacent cSAH | 0.043 | 4.179 | 1.046–16.697 |
Remote cSAH | 0.874 | 1.187 | 0.141–9.978 |
Intraventricular hemorrhage presence | 0.345 | 1.878 | 0.508–6.934 |
7 patients with missing data.
28 patients with missing data.
13 patients with missing data.
7 patients with missing data.
30 patients with missing data.
cSAH, convexity subarachnoid hemorrhage; ICH, intracerebral hemorrhage.